Novel Insights into the Pleiotropic Neuroprotective Action of Synthetic Halogen Free Thyronamine-like Analogues
Molecules · 14.08.2026 · 31 (16) · 2833
DOI: 10.3390/molecules31162833 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 14.08.2026. Verfasst von Massimiliano Runfola und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of Pisa, Via Bonanno 6, 56126 Pisa, Italy. Hauptthemen laut MEDLINE: Neuroprotective Agents, Alzheimer Disease. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, Region of Tuscany, Pfizer.
Abstract (Originalsprache)
Alzheimer’s disease (AD) is a multifactorial neurodegenerative disorder involving metabolic impairment, neuroinflammation, synaptic failure, and comorbidities. Hence, therapeutic development for AD is rapidly shifting from a single-target approach, centred on amyloid-beta (Aβ) reduction, to multi-target strategies. In this study, we investigated the neuroprotective profile of two acetanilide derivatives, SG-22 and SG-23, originated from the halogen-free thyronamine-like lead compound SG-2. Their efficacy was evaluated through an integrated approach combining in vitro cellular models, in vivo phenotypic screening in a Caenorhabditis elegans AD model, and comprehensive ADME-Tox profiling. In U87MG cells, both SG-22 and SG-23 effectively prevented Aβ25–35-induced cytotoxicity and restored autophagy-related gene expression, including LC3, SIRT1, and SIRT6, while reducing mTOR and SIRT5 levels. Furthermore, all compounds exhibited anti-inflammatory effects in activated HMC3 microglial cells, reducing IL-6 and increasing IL-10 levels, with evidence suggesting partial involvement of TAAR1 signalling. ADME-Tox analyses revealed improved safety and metabolic profiles for the tested compounds, particularly SG-22, which showed reduced hERG liability and enhanced cytochrome P450 stability. However, in vivo studies demonstrated that only SG-2 and SG-23 improved motility and fitness in the C. elegans AD model, consistent with their ability to activate autophagy, whereas SG-22 was ineffective due to limited organismal uptake. Ultimately, the monoacetylated analogue SG-23 emerges as a promising candidate, balancing neuroprotective efficacy and drug-like properties, and supporting thyronamine-like analogues as multi-target agents for AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, University of Pisa, Via Bonanno 6, 56126 Pisa, Italy.
- Department of Surgical, Medical, Molecular Pathology and Critical Care, University of Pisa, Via Savi 10, 56100 Pisa, Italy.
- Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Discovery Research ScreeningPort, 22525 Hamburg, Germany.
- Department of Chemistry and Industrial Chemistry, University of Pisa, Via Giuseppe Moruzzi 13, 56124 Pisa, Italy.
- Center for Instrument Sharing, University of Pisa (CISUP), Lungarno Pacinotti 43, 56126 Pisa, Italy.
ORCID-Profile: Massimiliano Runfola, Beatrice Polini, Lorenzo Raffellini, Fabio Di Ricco, Simona Sagona, Sheraz Gul, Marco Lessi, Rosarita D'Orsi, Fabio Bellina, Grazia Chiellini, Simona Rapposelli
Förderung
- NIH HHS
- Region of Tuscany
- Pfizer
- PNRR Tuscany Health Ecosystem (THE) - Spoke n. 02 "Preventive and Predictive Medicine
- Tuscany Region
- Tuscany Health Ecosystem (THE)—Spoke n. 02 “Preventive and Predictive Medicine”
Zitieren
APA
Runfola, M., Polini, B., Mazzierli, A., Raffellini, L., Di Ricco, F., Cirone, I., Sagona, S., Gul, S., Lessi, M., Cuzzola, A. R., D'Orsi, R., Bellina, F., Manera, C., Chiellini, G., & Rapposelli, S. (2026). Novel Insights into the Pleiotropic Neuroprotective Action of Synthetic Halogen Free Thyronamine-like Analogues. Molecules, 31(16), 2833. https://doi.org/10.3390/molecules31162833
Vancouver
Runfola M, Polini B, Mazzierli A, Raffellini L, Di Ricco F, Cirone I, et al. Novel Insights into the Pleiotropic Neuroprotective Action of Synthetic Halogen Free Thyronamine-like Analogues. Molecules. 2026;31(16):2833. doi:10.3390/molecules31162833
BibTeX
@article{Runfola2026,
author = {Runfola, Massimiliano and Polini, Beatrice and Mazzierli, Anna and Raffellini, Lorenzo and Di Ricco, Fabio and Cirone, Italo and Sagona, Simona and Gul, Sheraz and Lessi, Marco and Cuzzola, Angela Rosa and D'Orsi, Rosarita and Bellina, Fabio and Manera, Clementina and Chiellini, Grazia and Rapposelli, Simona},
title = {Novel Insights into the Pleiotropic Neuroprotective Action of Synthetic Halogen Free Thyronamine-like Analogues},
journal = {Molecules},
year = {2026},
volume = {31},
number = {16},
pages = {2833},
doi = {10.3390/molecules31162833}
}
EUVIMED